| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions /fa | 06/07/2024 | |
| 4 | Statement of changes in beneficial owner... | Tyson Timothy | Donnelley Financial Solutions /fa | 06/07/2024 | |
| 4 | Statement of changes in beneficial owner... | Tyson Timothy | Donnelley Financial Solutions File16 /fa | 06/02/2023 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions File16 /fa | 06/02/2023 | |
| 4 | Statement of changes in beneficial owner... | Tyson Timothy | Donnelley Financial Solutions File16 /fa | 06/02/2023 | |
| 4/A | Amendment to Statement of changes in ben... | Tyson Timothy | Donnelley Financial Solutions File16 /fa | 04/20/2023 | |
| 4/A | Amendment to Statement of changes in ben... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions File16 /fa | 04/20/2023 | |
| 4/A | Amendment to Statement of changes in ben... | Tyson Timothy | Donnelley Financial Solutions File16 /fa | 04/20/2023 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions File16 /fa | 10/03/2022 | |
| 4 | Statement of changes in beneficial owner... | Tyson Timothy | Donnelley Financial Solutions File16 /fa | 10/03/2022 | |
| Load More |